BCRX SCHEDULE 13G/A: SEC filing
RA Capital Management, L.P. and affiliated reporting persons
Filed with the SEC on · accession 0001346824-26-000275
BCRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 0% of BioCryst Pharmaceuticals common stock as of September 30, 2026, down from a previously reported position. The stock moved -2.1% by the first close after the filing.
Summary of the filing
RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 0% of BioCryst Pharmaceuticals common stock as of September 30, 2026, down from a previously reported position. The filing is a passive investment disclosure with no stated intent to influence control.
Key details
How BCRX stock reacted
Close before
$7.61
Nov 13, 2026
First close after
-2.10%
$7.45
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for BCRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BCRX?
Click hereFrequently asked questions
What did BCRX file with the SEC on Nov 16, 2026?
BCRX filed a SCHEDULE 13G/A (SEC filing). RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 0% of BioCryst Pharmaceuticals common stock as of September 30, 2026, down from a previously reported position. The filing is a passive investment disclosure with no stated intent to influence control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did BCRX stock react to this filing?
BCRX closed at $7.61 before the filing and $7.45 on Nov 16, 2026 (-2.10%).
Other BCRX SEC filings
- SCHEDULE 13G · SEC filingNov 10, 2026
- 10-Q · SEC filingNov 4, 2026
- 8-K · Guidance raiseNov 4, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · Guidance raiseAug 5, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · RestatementAug 4, 2026
- 8-K · SEC filingJun 29, 2026
- 8-K · SEC filingJun 12, 2026
- 10-Q · SEC filingMay 6, 2026
Get alerts when BCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days